←
Jazz Pharmaceuticals1,572 posts
Jazz Pharmaceuticals avatar✓

Jazz Pharmaceuticals ✓

@JazzPharma

We’re a global biopharma company developing life-changing medicines for people with rare disease. Please see our social guidelines - u.nu/cqmf

◷ Joined April 2017▧ 789 Photos and videos
Jazz Pharmaceuticals avatar
Jazz Pharmaceuticals@JazzPharma·Nov 16

Thank you for connecting with us on X. Jazz is aware of the situation. When possible, we work with healthcare providers to enable compassionate access to our medicines. For privacy reasons, we are unable to share more details.

Jazz Pharmaceuticals avatar
Jazz Pharmaceuticals@JazzPharma·Nov 2

For U.S. media and investors: At #SNO2026, we will present new clinical and preclinical research, highlighting our commitment to scientific innovation for people with rare and aggressive brain tumors. Learn more: bit.ly/4A5E2jv

Post attachment
Jazz Pharmaceuticals avatar
Jazz Pharmaceuticals@JazzPharma·Sep 15

We're pleased to announce the successful completion of our acquisition of Actio Biosciences, further strengthening our neuroscience portfolio and expanding our work in rare epilepsies. Learn more: bit.ly/4xp9Yxu

0:13
Jazz Pharmaceuticals avatar
Jazz Pharmaceuticals@JazzPharma·Aug 31

Today, we announced positive combination survival results from the Phase 3 HERIZON-GEA-01 trial investigating our first-line treatment for adults with HER2+ advanced gastroesophageal adenocarcinoma (GEA). Learn more: bit.ly/4cmRm9P

Post attachment
Jazz Pharmaceuticals avatar
Jazz Pharmaceuticals@JazzPharma·Aug 25

#News for U.S. media and investors: The U.S. FDA has approved our HER2-targeted therapy as part of two first-line treatment regimens for adults with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). Learn more: bit.ly/46ntmjm

0:17
Jazz Pharmaceuticals avatar
Jazz Pharmaceuticals@JazzPharma·Aug 10

We're pleased to announce a definitive agreement to acquire Actio Biosciences, adding to our #epilepsy portfolio and reinforcing our commitment to bringing meaningful treatments to people living with rare diseases. Subject to customary closing conditions. bit.ly/4wCElAt

0:13
Jazz Pharmaceuticals avatar
Jazz Pharmaceuticals@JazzPharma·Jun 25

We’re proud to share our 2025 Corporate Sustainability and Social Impact (CSSI) Report. It reflects how we’re advancing our purpose, delivering impact and building trust with key stakeholders. Read more: bit.ly/4b9oUYe

Post attachment
Jazz Pharmaceuticals avatar
Jazz Pharmaceuticals@JazzPharma·Jun 15

We are excited to be on the ground at #SLEEP2026 this week, where we are connecting with fellow leaders in the sleep community, like @American_Heart, to share more on the critical connection between sleep, sodium intake and hypertension. Learn more below.

Post attachment
Jazz Pharmaceuticals avatar
Jazz Pharmaceuticals@JazzPharma·Jun 11

Global Head of R&D and Chief Medical Officer Rob Iannone sat down with @FiercePharma to discuss the evolving HER2-targeted treatment landscape and Jazz’s strategic focus in HER2 to help address unmet needs for patients. Watch the full interview: bit.ly/4egsZuJ

0:42